在患有高胆固醇血症和混合失脂血症的患者中,提高LDL的药理管理
1Faculty of Medicine, Macau University of Science & Technology, Macau, China.
Expert opinion on pharmacotherapy
|March 5, 2026
概括
降低低密度脂蛋白胆固醇 (LDL-C) 是预防动脉样硬化心血管疾病 (ASCVD) 的关键. 新的疗法正在出现,以帮助患者达到LDL-C目标,当他类药物不足时.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 脂质学 脂质学是指脂质学.
背景情况:
- 低密度脂蛋白胆固醇 (LDL-C) 是降低动脉样硬化心血管疾病 (ASCVD) 风险的主要目标.
- 生活方式和饮食是最初的管理步骤,但对于高胆固醇血症和混合性脂质失调症,药物干预通常是必要的.
研究的目的:
- 审查目前用于降低LDL-C的治疗方法.
- 在晚期开发中引入新药,用于降低LDL-C.
主要方法:
- 为了确定相关的文章,进行了PubMed搜索.
- 该审查侧重于用于LDL-C管理的既定和新兴药理干预措施.
主要成果:
- 类药物是第一线疗法,但往往无法达到积极的LDL-C目标.
- 埃泽蒂米布和贝佩多酸是有效的补充或替代口服疗法.
- 可注射的PCSK9抑制剂是非常有效的,但面临的挑战是成本和患者的坚持.
- 新兴的口服PCSK9抑制剂和obicetrapib显示出安全性和有效性的承诺.
结论:
- 虽然目前和新兴的疗法为减少LDL-C提供了选择,但长期坚持仍然是一个挑战.
- 与注射疗法相比,新的口服药物可能会改善可访问性和坚持性.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.6K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.6K
Atherosclerosis III: Management
532
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
532
Coronary Artery Disease IV: Preventive Measures
784
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
784
Cholesterol: Significance and Regulation
1.8K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.8K
Angina IV: Management
368
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
368
Pharmacogenomics: Identification of New Drug Targets
55
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
55


